Sechenov School
Home › Biochemistry › Lipoproteins

Lipoproteins

Lipoproteina

For medical students2 min readUpdated 2026-10-10

Lipoproteins are complex macromolecular assemblies of lipids and specific proteins (apolipoproteins) that transport water-insoluble lipids and cholesterol in the blood. They are synthesized in the liver and intestine, undergoing a complex cycle of maturation, component exchange, and tissue uptake in the plasma.

VLDL SynthesisOccurs in hepatocytes with the participation of microsomal triglyceride transfer protein
APOB GeneticsThe liver translates 100% of the gene (apoB-100), whereas the intestine translates 48% (apoB-48)
Main DonorHDL donates apoE and apoC-II to immature particles
LCAT EnzymeEsterifies cholesterol on the surface of HDL

Major Classes of Lipoproteins

Lipoprotein particles vary in density, size, and composition:

Formation and Maturation of VLDL

VLDL synthesis occurs in hepatocytes. The liver maintains a total cholesterol pool comprising both exogenous (dietary) and endogenous (de novo synthesized) cholesterol.

Along with TAGs, this cholesterol is packaged into immature VLDL. A critical role in this process is played by the microsomal triglyceride transfer protein (MTP), which transfers TAGs into the nascent lipoprotein particle. The structural backbone is provided by the apoB-100 protein.

Upon entering the bloodstream, immature VLDL particles encounter HDL, from which they acquire apoE and apoC-II. Only after acquiring these apolipoproteins do VLDL particles become mature and fully functional.

HDL Metabolism and Cholesterol Ester Transport

HDL is synthesized in the liver and intestine as immature (discoid) particles. Immediately upon entering the circulation, they act as donors of apoC-II and apoE to chylomicrons and VLDL.

Nexting begins the scavenging function: HDL picks up excess cholesterol. The enzyme lecithin-cholesterol acyltransferase (LCAT), activated by apoA-I, operates on their surface. LCAT converts free cholesterol into cholesteryl esters (CE) and sequesters them into the hydrophobic core of the particle.

As cholesteryl esters accumulate, the discoid particle transforms into spherical HDL₃, and upon further enrichment, into larger HDL₂. Subsequently, cholesteryl ester transfer protein (CETP) acts to transfer CEs from HDL to LDL or VLDL in exchange for TAGs.

To complete the cycle, hepatic lipase on the surface of hepatocytes hydrolyzes TAGs within HDL₂, reducing their size and converting them back into HDL₃.

Mechanisms of Cholesterol Return to the Liver

The collected cholesteryl esters return to hepatocytes via three pathways:

  1. Endocytosis via LDL Receptors (Primary pathway): Hepatic receptors recognize apoB-100 and apoE located on the surface of remnant chylomicrons, IDL, and LDL.
  2. Scavenger Receptors (SR-B1): This pathway mediates the selective uptake of cholesteryl esters from HDL into hepatocytes, especially following modification by hepatic lipase.
  3. HDL Endocytosis (Minor pathway): A small fraction of HDL is endocytosed intact by cells via interactions between its apolipoproteins and specific receptors.

Isoforms of Lipoprotein Lipase (LPL)

Lipoprotein lipase, the enzyme responsible for hydrolyzing triglycerides within lipoproteins, exists in tissue-specific isoforms that differ in substrate affinity as represented by the Michaelis constant ($K_m$):

Frequently asked questions

What are the functions of apolipoprotein C-II?

Apolipoprotein C-II functions primarily as an activator of lipoprotein lipase.

  • Enzyme Activation — Lipoprotein lipase "recognizes" chylomicrons through interaction with apoC-II; the enzyme then hydrolyzes TAGs within chylomicrons into glycerol and free fatty acids.
  • Lipoprotein Maturation — ApoC-II is transferred from HDL to immature chylomicrons and VLDL, rendering them mature.

A deficiency of apoC-II is the underlying genetic defect in familial type I hyperchylomicronemia, characterized by elevated levels of chylomicrons and VLDL, and marked hypertriglyceridemia.

What happens in the event of an LDL receptor defect?

An LDL receptor defect impairs the tissue uptake of low-density lipoproteins due to a loss of receptor-mediated endocytosis.

These disruptions lead to the following changes:

  • Lipid Accumulation — Defective LDL clearance causes plasma cholesterol to accumulate, while intracellular cholesterol depletion fails to suppress endogenous hepatic cholesterol synthesis.
  • Disease Development — Primary familial hypercholesterolemia (Type IIa) develops.
  • Clinical Manifestations — Characterized by severe premature coronary atherosclerosis and xanthomas.
Why do VLDL contain apoB-100 while chylomicrons contain apoB-48, given they share the same gene?

This is due to post-transcriptional modification (RNA editing). The liver translates 100% of the coding sequence of the gene, producing apoB-100. Intestinal cells introduce a premature stop codon, translating only 48% of the sequence to yield the truncated protein apoB-48.

How do immature VLDL particles become mature?

In the bloodstream, they interact with HDL, which transfers apoE and apoC-II to them. Acquiring these apolipoproteins converts VLDL into mature particles capable of interacting with tissue enzymes and receptors.

What is the function of CETP?

It mediates lipid exchange between lipoproteins: it extracts cholesteryl esters from HDL and transfers them to VLDL and LDL in exchange for triacylglycerols (TAGs).

Go deeper

More topics in Biochemistry

GlycolysisBile AcidsAdrenal Gland DisordersRegulation of Pyrimidine Nucleotide SynthesisImmunoglobulins (Antibodies)Anaplerotic ReactionsPhenylalanine and Tyrosine MetabolismFasting Metabolism: Biochemical Pathways and AdaptationsPyrimidine Nucleotide Salvage PathwaysPhysicochemical Properties of ProteinsAscorbic AcidRegulation of Gene Expression in ProkaryotesBiochemistry →